Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: CBLB612|DRUG: Placebo
Sponsor: BioLab 612 LLC
Collaborators: Cleveland BioLabs, Inc.